Liprin-alpha-1 antibody
Principal name
Liprin-alpha-1 antibody
Alternative names for Liprin-alpha-1 antibody
PPFIA1, LIP1, PTPRF-interacting protein alpha-1, LAR-interacting protein 1, LIP.1, Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1
SwissProt ID
Q13136 (Human)
Gene ID
8500 (PPFIA1)
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of Liprin-alpha-1 antibody
- Kit Component:
- - KN205488G1, PPFIA1 gRNA vector 1 in pCas-Guide vector
- KN205488G2, PPFIA1 gRNA vector 2 in pCas-Guide vector
- KN205488D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunohistochemistry: Liprin alpha 1 Antibody - Most of the normal tissues displayed moderate cytoplasmic positivity which was occasionally accompanied with nuclear staining. Strong cytoplasmic staining was found in gastro-intestinal tract, gall bladder and endocrine glands. Malignant tissues generally exhibited moderate cytoplasmic immunoreactivity. A few cases of colo-rectal, endometrial, gastric and pancreatic cancers revealed strong staining while many skin cancers were weakly stained. Image and statement courtesy of the Human Protein Atlas (HPA).
Western Blot: Liprin alpha 1 Antibody - Samples: Lane 1, Marker: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil , Target weight: 136, 134 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.
ELISA: Liprin alpha 1 Antibody
Liprin alpha 1 antibody [N1N2], N-term detects PPFIA1 protein by Western blot analysis. A. 30 ug Neuro2A whole cell lysate/extract. 5 % SDS-PAGE. Liprin alpha 1 antibody [N1N2], N-term (TA308315) dilution: 1:1000
Sample (30 ug of whole cell lysate). A: JurKat. 5% SDS PAGE. TA308315 diluted at 1:10000.
Immunofluorescence analysis of methanol-fixed A431, using Liprin alpha 1(TA308315) antibody at 1:200 dilution.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA308315 | Liprin-alpha-1 antibody |
||||||
| Rabbit Polyclonal antibody to Liprin alpha 1 (protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1) | |||||||
![Liprin alpha 1 antibody [N1N2], N-term detects PPFIA1 protein by Western blot analysis. A. 30 ug Neuro2A whole cell lysate/extract. 5 % SDS-PAGE. Liprin alpha 1 antibody [N1N2], N-term (TA308315) dilution: 1:1000](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/OriGene/GTX115098-1-W.jpg) |
Rabbit | IgG | Aff - Purified | Hu, Ms | ICC/IF, WB |
0.1 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
| TA590366 | Liprin-alpha-1 antibody |
||||||
| Rabbit Polyclonal Liprin alpha 1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, P, WB |
0.1 mg /
€409.00
|
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP312893 | Liprin-alpha-1 (transcript variant 1) |
||||
| Recombinant protein of human protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€788.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406160 | PPFIA1 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |